Related Experiment Video
Updated: Feb 5, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Diflunisal-adjoined cobalt(iii)-polypyridyl complexes as anti-cancer stem cell agents
David O Abe1, Arvin Eskandari, Kogularamanan Suntharalingam
1Department of Chemistry, King's College London, London, UK. kogularamanan.suntharalingam@kcl.ac.uk.
Abstract:
We report a novel series of cobalt(iii)-polypridyl complexes, 4-6, that can selectively release diflunisal, a nonsteroidal anti-inflammatory drug, under reducing conditions. Remarkably, the 1,10-phenanthroline-bearing complex 5 displays selective potency towards hard-to-kill cancer stem cells (CSCs) (IC50 = 2.1 ± 0.1 μM) over bulk cancer (IC50 = 3.9 ± 0.2 μM) and normal cells (IC50 = 21.2 ± 1.3 μM). This complex induces CSC apoptosis by DNA damage and cyclooxygenase-2 inhibition.
More Related Videos
Related Concept Videos
Formation of Complex Ions
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Electron Transport Chain: Complex III and IV
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

